These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 29483115)
1. An Antibiotic Stewardship Program Blueprint for Optimizing Verigene BC-GN within an Institution: a Tale of Two Cities. Pogue JM; Heil EL; Lephart P; Johnson JK; Mynatt RP; Salimnia H; Claeys KC Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29483115 [TBL] [Abstract][Full Text] [Related]
2. Rapid testing using the Verigene Gram-negative blood culture nucleic acid test in combination with antimicrobial stewardship intervention against Gram-negative bacteremia. Bork JT; Leekha S; Heil EL; Zhao L; Badamas R; Johnson JK Antimicrob Agents Chemother; 2015 Mar; 59(3):1588-95. PubMed ID: 25547353 [TBL] [Abstract][Full Text] [Related]
3. Impact of antimicrobial stewardship and rapid microarray testing on patients with Gram-negative bacteremia. Rivard KR; Athans V; Lam SW; Gordon SM; Procop GW; Richter SS; Neuner E Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1879-1887. PubMed ID: 28534213 [TBL] [Abstract][Full Text] [Related]
4. Pediatric multicenter evaluation of the Verigene gram-negative blood culture test for rapid detection of inpatient bacteremia involving gram-negative organisms, extended-spectrum beta-lactamases, and carbapenemases. Sullivan KV; Deburger B; Roundtree SS; Ventrola CA; Blecker-Shelly DL; Mortensen JE J Clin Microbiol; 2014 Jul; 52(7):2416-21. PubMed ID: 24759724 [TBL] [Abstract][Full Text] [Related]
5. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia. Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135 [TBL] [Abstract][Full Text] [Related]
6. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study]. Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074 [TBL] [Abstract][Full Text] [Related]
7. Identification of Gram-Negative Bacteria and Genetic Resistance Determinants from Positive Blood Culture Broths by Use of the Verigene Gram-Negative Blood Culture Multiplex Microarray-Based Molecular Assay. Ledeboer NA; Lopansri BK; Dhiman N; Cavagnolo R; Carroll KC; Granato P; Thomson R; Butler-Wu SM; Berger H; Samuel L; Pancholi P; Swyers L; Hansen GT; Tran NK; Polage CR; Thomson KS; Hanson ND; Winegar R; Buchan BW J Clin Microbiol; 2015 Aug; 53(8):2460-72. PubMed ID: 25994165 [TBL] [Abstract][Full Text] [Related]
8. The Hypothetical Impact of Accelerate Pheno on Time to Effective Therapy and Time to Definitive Therapy for Bloodstream Infections Due to Drug-Resistant Gram-Negative Bacilli. Henig O; Kaye KS; Chandramohan S; Cooper CC; Lephart P; Salimnia H; Taylor M; Pogue JM Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559141 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of Verigene Blood Culture Test Systems for Rapid Identification of Positive Blood Cultures. Kim JS; Kang GE; Kim HS; Kim HS; Song W; Lee KM Biomed Res Int; 2016; 2016():1081536. PubMed ID: 26904669 [TBL] [Abstract][Full Text] [Related]
10. Experience With Rapid Microarray-Based Diagnostic Technology and Antimicrobial Stewardship for Patients With Gram-Positive Bacteremia. Neuner EA; Pallotta AM; Lam SW; Stowe D; Gordon SM; Procop GW; Richter SS Infect Control Hosp Epidemiol; 2016 Nov; 37(11):1361-1366. PubMed ID: 27767002 [TBL] [Abstract][Full Text] [Related]
11. Clinical Impact of Laboratory Implementation of Verigene BC-GN Microarray-Based Assay for Detection of Gram-Negative Bacteria in Positive Blood Cultures. Walker T; Dumadag S; Lee CJ; Lee SH; Bender JM; Cupo Abbott J; She RC J Clin Microbiol; 2016 Jul; 54(7):1789-1796. PubMed ID: 27098961 [TBL] [Abstract][Full Text] [Related]
12. Prospective intervention study with a microarray-based, multiplexed, automated molecular diagnosis instrument (Verigene system) for the rapid diagnosis of bloodstream infections, and its impact on the clinical outcomes. Suzuki H; Hitomi S; Yaguchi Y; Tamai K; Ueda A; Kamata K; Tokuda Y; Koganemaru H; Kurihara Y; Ishikawa H; Yanagisawa H; Yanagihara K J Infect Chemother; 2015 Dec; 21(12):849-56. PubMed ID: 26433422 [TBL] [Abstract][Full Text] [Related]
13. Multicenter evaluation of the Verigene Gram-negative blood culture nucleic acid test for rapid detection of bacteria and resistance determinants in positive blood cultures. Uno N; Suzuki H; Yamakawa H; Yamada M; Yaguchi Y; Notake S; Tamai K; Yanagisawa H; Misawa S; Yanagihara K Diagn Microbiol Infect Dis; 2015 Dec; 83(4):344-8. PubMed ID: 26361710 [TBL] [Abstract][Full Text] [Related]
14. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis. Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741 [TBL] [Abstract][Full Text] [Related]
15. Cumulative Effect of an Antimicrobial Stewardship and Rapid Diagnostic Testing Bundle on Early Streamlining of Antimicrobial Therapy in Gram-Negative Bloodstream Infections. Bookstaver PB; Nimmich EB; Smith TJ; Justo JA; Kohn J; Hammer KL; Troficanto C; Albrecht HA; Al-Hasan MN Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630187 [TBL] [Abstract][Full Text] [Related]
16. Cefepime-resistant Gram-negative bacteremia in febrile neutropenic patients with hematological malignancies. Chong Y; Yakushiji H; Ito Y; Kamimura T Int J Infect Dis; 2010 Sep; 14 Suppl 3():e171-5. PubMed ID: 20471883 [TBL] [Abstract][Full Text] [Related]
17. Antibiotic treatment algorithm development based on a microarray nucleic acid assay for rapid bacterial identification and resistance determination from positive blood cultures. Rödel J; Karrasch M; Edel B; Stoll S; Bohnert J; Löffler B; Saupe A; Pfister W Diagn Microbiol Infect Dis; 2016 Mar; 84(3):252-7. PubMed ID: 26712265 [TBL] [Abstract][Full Text] [Related]
18. Impact of rapid identification of positive blood cultures using the Verigene system on antibiotic prescriptions: A prospective study of community-onset bacteremia in a tertiary hospital in Japan. Hayakawa K; Mezaki K; Kobayakawa M; Yamamoto K; Mutoh Y; Tsuboi M; Hasimoto T; Nagamatsu M; Kutsuna S; Takeshita N; Katanami Y; Ishikane M; Ohmagari N PLoS One; 2017; 12(7):e0181548. PubMed ID: 28742143 [TBL] [Abstract][Full Text] [Related]
19. Rapid molecular tests for detection of antimicrobial resistance determinants in Gram-negative organisms from positive blood cultures: a systematic review and meta-analysis. De Angelis G; Grossi A; Menchinelli G; Boccia S; Sanguinetti M; Posteraro B Clin Microbiol Infect; 2020 Mar; 26(3):271-280. PubMed ID: 31751768 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the nanosphere Verigene BC-GN assay for direct identification of gram-negative bacilli and antibiotic resistance markers from positive blood cultures and potential impact for more-rapid antibiotic interventions. Hill JT; Tran KD; Barton KL; Labreche MJ; Sharp SE J Clin Microbiol; 2014 Oct; 52(10):3805-7. PubMed ID: 25122857 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]